申请人:Gant Thomas G.
公开号:US20100075916A1
公开(公告)日:2010-03-25
The present invention relates to new substituted quinazoline inhibitors of vascular endothelial growth factor receptor tyrosine kinase, epidermal growth factor receptor tyrosine kinase, and/or REarranged during Transfection tyrosine kinase, pharmaceutical compositions thereof, and methods of use thereof.
本发明涉及新的取代喹唑啉抑制剂,用于血管内皮生长因子受体酪氨酸激酶、表皮生长因子受体酪氨酸激酶和/或重排在转位期间酪氨酸激酶,以及其药物组合物和使用方法。